Innovation. Biological insight. Convergent technologies.
Atheron is a biotechnology company driven by a relentless pursuit of innovation. We are dedicated to addressing critical unmet clinical needs in oncology, autoimmune diseases, and inflammatory disorders. Based on deep insights into disease biology, we harness a drug discovery platform that integrates multiple frontier technologies to create transformative therapies for patients — redefining treatment paradigms and setting new standards of care.
Atheron currently operates a state-of-the-art laboratory spanning 1,400 square meters, supported by a dedicated team of 47 employees. The company’s laboratory instrument assets exceed 15 million, reflecting its commitment to building a robust research infrastructure capable of advancing its discovery pipeline.
